Journal article
Cell-mediated immunity in patients with basal and squamous cell skin cancer
Journal of the American Academy of Dermatology, Vol.2(2), pp.143-147
02/1980
DOI: 10.1016/S0190-9622(80)80393-8
PMID: 6965945
Abstract
T and B lymphocyte levels were normal in fifty patients with basal and squamous cell skin cancer. Patients with basal cell carcinomas and small squamous cell carcinomas reacted normally to intradermal antigens and to dinitrochlorobenzene (DNCB). However, patients with large (>3 cm) squamous cell carcinomas appeared to have defective systemic cell-mediated immunity because only 33% of them reacted to at least one intradermal antigen, and only 67% could be sensitized to DNCB. Presently, it is unknown whether this defect is related to the occurrence or behavior of squamous cell carcinoma. © 1980, American Academy of Dermatology, Inc.. All rights reserved.
Details
- Title: Subtitle
- Cell-mediated immunity in patients with basal and squamous cell skin cancer
- Creators
- Virginia M WeimarRoger I CeilleyJames A Goeken
- Resource Type
- Journal article
- Publication Details
- Journal of the American Academy of Dermatology, Vol.2(2), pp.143-147
- DOI
- 10.1016/S0190-9622(80)80393-8
- PMID
- 6965945
- NLM abbreviation
- J Am Acad Dermatol
- ISSN
- 0190-9622
- eISSN
- 1097-6787
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 02/1980
- Academic Unit
- Dermatology; Pathology
- Record Identifier
- 9984204114902771
Metrics
13 Record Views